Abstract:Epigallocatechin gallate (EGCG), a green tea catechin, has gained the attention of current study due to its excellent health-promoting effects. It possesses anti-obesity, antimicrobial, anticancer, anti-inflammatory activities, and is under extensive investigation in functional foods for improvement. It is susceptible to lower stability, lesser bioavailability, and lower absorption rate due to various environmental, processing, formulations, and gastrointestinal conditions of the human body. Therefore, it is the foremost concern for the researchers to enhance its bioactivity and make it the most suitable therapeutic compound for its clinical applications. In the current review, factors affecting the bioavailability of EGCG and the possible strategies to overcome these issues are reviewed and discussed. This review summarizes structural modifications and delivery through nanoparticle-based approaches including nano-emulsions, encapsulations, and silica-based nanoparticles for effective use of EGCG in functional foods. Moreover, recent advances to enhance EGCG therapeutic efficacy by specifically targeting its molecules to increase its bioavailability and stability are also described. PRACTICAL APPLICATIONS: The main green tea constituent EGCG possesses several health-promoting effects making EGCG a potential therapeutic compound to cure ailments. However, its low stability and bioavailability render its uses in many disorders. Synthesizing EGCG prodrugs by structural modifications helps against its low bioavailability and stability by overcoming premature degradation and lower absorption rate. This review paper summarizes various strategies that benefit EGCG under different physiological conditions. The esterification, nanoparticle approaches, silica-based EGCG-NPs, and EGCG formulations serve as ideal EGCG modification strategies to deliver superior concentrations with lesser toxicity for its efficient penetration and absorption across cells both in vitro and in vivo. As a result of EGCG modifications, its bioactivities would be highly improved at lower doses. The protected or modified EGCG molecule would have enhanced potential effects and stability that would contribute to the clinical applications and expand its use in various food and cosmetic industries.

Food-Grade Encapsulation Systems For (-)-Epigallocatechin Gallate

Fabrication of Zein-Lecithin-EGCG complex nanoparticles: Characterization, controlled release in simulated gastrointestinal digestion.

Improved in Vitro Digestion Stability of (−)-Epigallocatechin Gallate Through Nanoliposome Encapsulation

EGCG-based nanoparticles: synthesis, properties, and applications

Encapsulation of (─)-epigallocatechin-3-gallate (EGCG) in solid lipid nanoparticles for food applications

Chemico-biological aspects of (−)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects

Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies

Encapsulation of (−)-Epigallocatechin-gallate (EGCG) in Hordein Nanoparticles

Epigallocatechin-3-gallate(EGCG) : Mechanisms and the Combined Applications.

Development of gelatinized-core liposomes for the oral delivery of EGCG with improved stability, release property, and cellular antioxidant activity

Comprehensive Review of EGCG Modification: Esterification Methods and Their Impacts on Biological Activities

Encapsulation of EGCG by Whey Protein Isolate and (3-Cyclodextrin Nanocomplexes: A Strategy to Mask the Bitter and Astringent Taste and Increase the Stability in Beverages

Optimized Epigallocatechin Gallate Delivery and Adipogenesis Inhibition through Fluorescent Mesoporous Nanocarriers

Coencapsulation of (-)-epigallocatechin-3-gallate and Quercetin in Particle-Stabilized W/O/W Emulsion Gels: Controlled Release and Bioaccessibility.

Encapsulation of EGCG by Zein-Gum Arabic Complex Nanoparticles and In Vitro Simulated Digestion of Complex Nanoparticles

Encapsulation Alleviates the Auto-browning of Epigallocatechin-3-gallate in Aqueous Solutions Through Regulating Molecular Self-Aggregation Behavior.

Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate

Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions

Application of Microencapsulation for the Safe Delivery of Green Tea Polyphenols in Food Systems: Review and Recent Advances

Preparation and characterization of chitosan films incorporating epigallocatechin gallate: Microstructure, physicochemical, and bioactive properties

Native and Thermally Modified Protein-Polyphenol Coassemblies: Lactoferrin-Based Nanoparticles and Submicrometer Particles As Protective Vehicles for (-)-Epigallocatechin-3-gallate.